AC Immune (ACIU) Assets (2015 - 2026)
AC Immune (ACIU) posted quarterly Assets of $175.5 billion for Q1 2026, up 74646.66% year-over-year from N/an in Q1 2025, and up 90828.78% quarter-over-quarter from $193.0 million in Q4 2025.
AC Immune (ACIU) Assets (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Assets for 12 consecutive years, with $175.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 74646.66% year-over-year to $175.5 billion; the TTM figure through Mar 2026 stood at $175.5 billion (up 74646.66% YoY), while the FY2025 annual figure was $186.0 million, down 29.42% from the prior year.
- Assets improved to $175.5 billion in Q1 2026 per ACIU's latest filing, from $193.0 million in the prior quarter.
- Across five years, Assets topped out at $175.5 billion in Q1 2026 and bottomed at $225087.4 in Q2 2022.
- Historically, Assets has averaged $10.5 billion across 5 years, with a median of $206.1 million in 2023.
- On a YoY basis, Assets climbed as much as 95982.08% in 2022 and fell as far as 31.93% in 2022.
- AC Immune's Assets stood at $193.0 million in 2022, then gained by 6.78% to $206.1 million in 2023, then rose by 27.9% to $263.6 million in 2024, then declined by 26.78% to $193.0 million in 2025, then jumped by 90828.78% to $175.5 billion in 2026.
- Business Quant data shows ACIU's Assets at $175.5 billion in Q1 2026, $193.0 million in Q4 2025, and $214.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 190.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 190.29 Mn |
| Mar 31, 2026 | 175.49 Bn |
| Dec 31, 2025 | 192.99 Mn |
| Sep 30, 2025 | 214.53 Mn |
| Jun 30, 2025 | 229.77 Mn |
| Mar 31, 2025 | 234.78 Mn |
| Dec 31, 2024 | 263.59 Mn |
| Sep 30, 2024 | 281.91 Mn |
| Jun 30, 2024 | 262.66 Mn |
| Mar 31, 2024 | 191.65 Mn |
| Dec 31, 2023 | 206.10 Mn |
| Sep 30, 2023 | 161.88 Mn |
| Jun 30, 2023 | 173.75 Mn |
| Mar 31, 2023 | 182.88 Mn |
| Dec 31, 2022 | 193.01 Mn |
| Sep 30, 2022 | 212.85 Mn |
| Jun 30, 2022 | 225,087.39 |
| Mar 31, 2022 | 255,021.95 |
| Dec 31, 2021 | 283.54 Mn |
| Sep 30, 2021 | 221,524.50 |